University of Tennessee Health Science Center Team Awarded $2.27 Million for New Breast Cancer Therapy Research
April 04, 2020
April 04, 2020
MEMPHIS, Tennessee, April 4 [TNSmedicalresearch] -- The University of Tennessee Health Science Center issued the following news:
A research team at the University of Tennessee Health Science Center has been awarded $2.27 million to study a potential next-generation treatment for late-stage breast cancer.
Wei Li, PhD, professor of Pharmaceutical Sciences and director of the UTHSC College of Pharmacy Drug Discovery Center, and Tiffany Seagroves, PhD, professor of Patholog . . .
A research team at the University of Tennessee Health Science Center has been awarded $2.27 million to study a potential next-generation treatment for late-stage breast cancer.
Wei Li, PhD, professor of Pharmaceutical Sciences and director of the UTHSC College of Pharmacy Drug Discovery Center, and Tiffany Seagroves, PhD, professor of Patholog . . .